Breaking News Instant updates and real-time market news.

2017-05-18 06:28:25 INCY Incyte $120.49 2.73 (2.32%) 06:28 05/18/17 05/18 06:28 05/18/17 06:28	Incyte data to 'restore positive sentiment,' says JPMorgan JPMorgan analyst Cory Kasimov believes last night's abstracts for epacadostat demonstrate "consistent and compelling evidence" of efficacy across multiple tumor types, consistent with what Incyte has been telling with Street. The analyst is "encouraged" by emerging data and expect it will "restore positive sentiment" in the name and add to the company's perceived strategic value. He reiterates an Overweight rating on Incyte shares with a $149 price target.	22 May 02 Jun
INCY Incyte $120.49 2.73 (2.32%) 05/11/17 OPCO 05/11/17 INITIATION Target $125 OPCO Perform Incyte initiated with a Perform at Oppenheimer Oppenheimer analyst Jay Olson initiated Incyte with a Perform and a $125 price target to reflect the valuation premium driven by takeover speculation. The analyst has no insight into the speculation but also said expectations are high going into ASCO for Incyte's epacadostat to deliver impressive benefits in combo with Keytrude in lung cancer. 05/09/17 FBCO 05/09/17 NO CHANGE Target $152 FBCO Outperform Incyte price target lowered to $152 from $167 at Credit Suisse Credit Suisse analyst Alethia Young lowered her price target for Incyte to $152 from $167 due to moving from M&A base case valuation. While the analyst says it is possible that one day Incyte is bought, she thinks the company is progressing well in diversifying its pipeline base and de-risking its IDO inhibitor epacadostat. Young reiterates an Outperform rating on the shares. 05/05/17 LEER 05/05/17 NO CHANGE Target $134 LEER Outperform Incyte price target lowered to $134 from $141 at Leerink Leerink analyst Michael Schmidt raised his price target for Incyte to $134 from $141 as a result of more conservative baricitinib assumptions, partially offset by higher Jakafi estimates. The analyst reiterates an Outperform rating on the shares. 04/27/17 JMPS 04/27/17 NO CHANGE JMPS Incyte a takeover target after baricitinib setback, says JMP Securities JMP Securities analyst Liisa Bayko believes that Incyte is a takeover target after the FDA issued a complete response letter for the company's baricitinib drug. The analyst expects the stock to rise heading into ASCO in June. She keeps a $145 price target and an Outperform rating on Incyte.

2017-05-18 06:28:25

INCY

Incyte

$120.49: 2.73 (2.32%)

06:28

05/18/17

05/18

06:28

05/18/17

06:28

Incyte data to 'restore positive sentiment,' says JPMorgan

JPMorgan analyst Cory Kasimov believes last night's abstracts for epacadostat demonstrate "consistent and compelling evidence" of efficacy across multiple tumor types, consistent with what Incyte has been telling with Street. The analyst is "encouraged" by emerging data and expect it will "restore positive sentiment" in the name and add to the company's perceived strategic value. He reiterates an Overweight rating on Incyte shares with a $149 price target.

22
May
02
Jun

INCY Incyte

$120.49: 2.73 (2.32%)

05/11/17: OPCO

05/09/17: FBCO

05/05/17: LEER

04/27/17: JMPS

TODAY'S FREE FLY STORIES

DNKN Dunkin' Brands $58.32 0.15 (0.26%) 07:32 05/31/17 05/31 07:32 05/31/17 07:32 Hot Stocks	Dunkin' Brands names Kate Jaspon as CFO, effective June 5 » Dunkin' Brands Group… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Jun
EXAS Exact Sciences $32.65 -0.67 (-2.01%) , UNH UnitedHealth $176.59 -0.91 (-0.51%) 07:31 05/31/17 05/31 07:31 05/31/17 07:31 Recommendations	Exact Sciences, UnitedHealth analyst commentary » Exact Sciences remains a… EXAS Exact Sciences $32.65 -0.67 (-2.01%) UNH UnitedHealth $176.59 -0.91 (-0.51%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May 31 May 06 Jun
QCOM Qualcomm $57.34 -0.18 (-0.31%) , NXPI NXP Semiconductors $108.14 0.14 (0.13%) 07:31 05/31/17 05/31 07:31 05/31/17 07:31 Hot Stocks	Qualcomm extends cash tender offer for NXP Semiconductors outstanding shares » Qualcomm (QCOM) announced… QCOM Qualcomm $57.34 -0.18 (-0.31%) NXPI NXP Semiconductors $108.14 0.14 (0.13%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 Jun 09 Jun
FRO Frontline $5.41 -0.22 (-3.91%) 07:31 05/31/17 05/31 07:31 05/31/17 07:31 Upgrade	Frontline rating change » Frontline upgraded to Buy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
EGHT 8x8, Inc. $13.60 0.1 (0.74%) 07:30 05/31/17 05/31 07:30 05/31/17 07:30 Conference/Events	8x8, Inc. management to meet with Needham » Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May 01 Jun 06 Jun 06 Jun 08 Jun 13 Jun

GNRT Gener8 Maritime $4.91 0.06 (1.24%) , FRO Frontline $5.41 -0.22 (-3.91%) … 07:30 05/31/17 05/31 07:30 05/31/17 07:30 Recommendations	Gener8 Maritime, Frontline, DHT Holdings analyst commentary » Gener8 Maritime advance… GNRT Gener8 Maritime $4.91 0.06 (1.24%) FRO Frontline $5.41 -0.22 (-3.91%) DHT DHT Holdings $4.20 -0.07 (-1.64%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
WLL Whiting Petroleum $7.28 -0.69 (-8.66%) , ORCL Oracle $45.42 0.16 (0.35%) 07:30 05/31/17 05/31 07:30 05/31/17 07:30 Options	Unusual put flow in option market yesterday » Notable put activity was… WLL Whiting Petroleum $7.28 -0.69 (-8.66%) ORCL Oracle $45.42 0.16 (0.35%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
KORS Michael Kors $36.27 -0.49 (-1.33%) 07:25 05/31/17 05/31 07:25 05/31/17 07:25 Technical Analysis	Technical View: Michael Kors drops to new 52-week low after earnings » In the pre-market the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May
CBS CBS $61.52 -0.05 (-0.08%) , CBS.A $63.50 -0.15 (-0.24%) … 07:24 05/31/17 05/31 07:24 05/31/17 07:24 Periodicals	Scott Pelley to depart anchor role on 'CBS Evening News,' NY Times says » CBS (CBS, CBS.A) news… CBS CBS $61.52 -0.05 (-0.08%) CBS.A $63.50 -0.15 (-0.24%) CMCSA Comcast $41.10 0.19 (0.46%) CMCSK Comcast DIS Disney $108.34 -0.07 (-0.06%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 Jun 08 Jun 15 Jun
KORS Michael Kors $36.27 -0.49 (-1.33%) 07:23 05/31/17 05/31 07:23 05/31/17 07:23 Hot Stocks	Breaking Hot Stocks news story on Michael Kors » Michael Kors drops 7% in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May

UAA Under Armour $19.56 -0.13 (-0.66%) 07:23 05/31/17 05/31 07:23 05/31/17 07:23 Recommendations	Under Armour analyst commentary » Under Armour has reached… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May
07:22 05/31/17 05/31 07:22 05/31/17 07:22 General news	Futures higher ahead of final trading for May » Stock futures are above… Stock futures are above fair value as the final trading session of May is set to begin. World markets closed trading with gains for the month as investors stateside will be looking ahead to Friday's nonfarm payrolls report. Today though they will see the Chicago purchasing manager's report and pending home sales data. The weekly oil numbers, which are normally released on Wednesday, will be delayed until tomorrow due to the Memorial Day holiday. In early trading, Dow futures are 18 points above fair value, Nasdaq futures are 12 points above fair value and S&P futures are 2 points above fair value.
KORS Michael Kors $36.27 -0.49 (-1.33%) 07:22 05/31/17 05/31 07:22 05/31/17 07:22 Hot Stocks	Michael Kors says to close 100-125 full-price retail stores over next two years » Michael Kors announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	31 May
MYL Mylan $39.36 -0.36 (-0.91%) 07:19 05/31/17 05/31 07:19 05/31/17 07:19 Recommendations	Mylan analyst commentary » Pension fund campaign a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	03 Sep 09 Oct
VIAB Viacom $35.05 -0.08 (-0.23%) , VIA Viacom $38.90 0.5 (1.30%) 07:17 05/31/17 05/31 07:17 05/31/17 07:17 Recommendations	Viacom, Viacom analyst commentary » Viacom price target… VIAB Viacom $35.05 -0.08 (-0.23%) VIA Viacom $38.90 0.5 (1.30%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

XXII 22nd Century $1.37 -0.02 (-1.44%) 07:17 05/31/17 05/31 07:17 05/31/17 07:17 Hot Stocks	22nd Century reports 'dramatic surge' in VLN tobacco clinical trials, science » 22nd Century Group… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ABT Abbott $45.00 0.29 (0.65%) 07:16 05/31/17 05/31 07:16 05/31/17 07:16 Recommendations	Abbott analyst commentary » Abbott making progress, … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
GRMN Garmin $52.11 -0.29 (-0.55%) 07:15 05/31/17 05/31 07:15 05/31/17 07:15 Hot Stocks	Garmin launches Approach S60 golf watch » Garmin International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SLCA U.S. Silica $36.45 -0.76 (-2.04%) 07:15 05/31/17 05/31 07:15 05/31/17 07:15 Technical Analysis	Technical View: U.S. Silica trades higher in pre-market » In the pre-market the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	20 Jun
GPRK GeoPark $8.71 -0.18 (-2.02%) 07:12 05/31/17 05/31 07:12 05/31/17 07:12 Hot Stocks	GeoPark names Coulter Enterprises Chairman and CEO Coulter to board » GeoPark Limited announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

PRQR ProQR Therapeutics $4.70 -0.3 (-6.00%) 07:12 05/31/17 05/31 07:12 05/31/17 07:12 Hot Stocks	ProQR Therapeutics' QR-110 granted Fast Track designation by FDA » ProQR Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
MOH Molina Healthcare $66.30 -0.57 (-0.85%) 07:11 05/31/17 05/31 07:11 05/31/17 07:11 Downgrade	Molina Healthcare rating change » Molina Healthcare… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
GSK GlaxoSmithKline $43.41 0.74 (1.73%) 07:11 05/31/17 05/31 07:11 05/31/17 07:11 Technical Analysis	Technical View: GlaxoSmithKline rises in early trading » Shares were last up over… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Jun
RGNX Regenxbio $16.70 -1.3 (-7.22%) 07:09 05/31/17 05/31 07:09 05/31/17 07:09 Earnings	Regenxbio initiates Phase 1 clinical trial of RGX-314 for macular degeneration » Regenxbio has dosed the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
INCY Incyte $130.49 -3.89 (-2.89%) 07:08 05/31/17 05/31 07:08 05/31/17 07:08 Recommendations	Incyte analyst commentary » Incyte price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	02 Jun 13 Jun 15 Jun

Events

Earnings calls, analyst events, roadshows and more

Today at 08:00

Fed Bank President Kaplan Takes Part in a Discussion Government Event

New York, NY
JILL
Today at 08:00

J.Jill - JILL Conference Calls
KORS
Today at 08:00

Michael Kors - KORS Conference Calls
BWFG
Today at 08:00

Bankwell Financial Firm Sponsored Meetings

Woodway Country Club--540 Hoyt Street, Darien, CT
CUBE
Today at 08:00

CubeSmart Firm Sponsored Meetings

Co Offices--5 Old Lancaster Road, Malvern, PA
SCOR
Today at 08:30

comScore - SCOR Conference Calls
PRGO
Today at 08:30

Perrigo - PRGO Conference Calls
NVS
Today at 08:30

Novartis Firm Sponsored Meetings
ONCE
Today at 08:30

Spark Therapeutics Firm Sponsored Meetings

Offices of Ballard Spahr LLP--1735 Market Street, Philadelphia, PA
Today at 08:55

Redbook Store Sales Y/Y: Week 5/27 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	ARI X ARI Apollo Commercial Spot Secondary Managers: Citi, JPMorgan, BofA/Merrill & Morgan Stanley $18.25-18.60 1.2M Shares JRVR X JRVR James River Group Spot Secondary Managers: Morgan Stanley $40.00-41.00 4.25M Shares STAY X STAY Extended Stay America Spot Secondary Managers: Morgan Stanley & Citi $17.50-17.60 2.5B Shares
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Incyte data to 'restore positive sentiment,' says JPMorgan

TODAY'S FREE FLY STORIES

Get Full Fly Access